Mackenzie Financial
IRWD icon

Mackenzie Financial’s Ironwood Pharmaceuticals IRWD Stock Holding History

Mackenzie Financial’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.97M Buy
2,367,493
+1,807,459
+323% +$6.97M 0.01% 637
2026
Q1 		$1.97M Buy
560,034
+548,490
+4,751% +$2.25M ﹤0.01% 933
2025
Q4 		$38.4K Buy
11,544
+1,084
+10% +$2.81K ﹤0.01% 1630
2025
Q3 		$13.7K Hold
10,460
– – ﹤0.01% 1687
2025
Q2 		$7.5K Hold
10,460
– – ﹤0.01% 1690
2025
Q1 		$15.4K Hold
10,460
– – ﹤0.01% 1653
2024
Q4 		$46.3K Hold
10,460
– – ﹤0.01% 1662
2024
Q3 		$43.1K Hold
10,460
– – ﹤0.01% 1544
2024
Q2 		$68.2K Hold
10,460
– – ﹤0.01% 1466
2024
Q1 		$91.1K Hold
10,460
– – ﹤0.01% 1430
2023
Q4 		$120K Sell
10,460
-2,253
-18% -$22.3K ﹤0.01% 1389
2023
Q3 		$123K Buy
12,713
+2,253
+22% +$22.1K ﹤0.01% 1331
2023
Q2 		$109K Hold
10,460
– – ﹤0.01% 1403
2023
Q1 		$110K Hold
10,460
– – ﹤0.01% 1400
2022
Q4 		$130K Buy
+10,460
New +$119K ﹤0.01% 1300
2021
Q1 		– Sell
-45,622
Closed -$520K – 1162
2020
Q4 		$520K Sell
45,622
-48,694
-52% -$533K ﹤0.01% 831
2020
Q3 		$848K Buy
94,316
+21,550
+30% +$214K ﹤0.01% 700
2020
Q2 		$751K Sell
72,766
-344
-0.5% -$3.52K ﹤0.01% 728
2020
Q1 		$738K Buy
73,110
+18,570
+34% +$218K ﹤0.01% 722
2019
Q4 		$726K Buy
+54,540
New +$601K ﹤0.01% 791
2014
Q2 		– Sell
-109,038
Closed -$1.13M – 655
2014
Q1 		$1.13M Buy
109,038
+56,878
+109% +$640K 0.01% 475
2013
Q4 		$507K Hold
52,160
– – ﹤0.01% 581
2013
Q3 		$517K Buy
52,160
+238
+0.5% +$2.33K ﹤0.01% 569
2013
Q2 		$432K Buy
+51,922
New +$629K ﹤0.01% 593

Other funds holding IRWD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Mackenzie Financial's IRWD Position: Q2 2026 in Review

Mackenzie Financial increased its Ironwood Pharmaceuticals (IRWD) stake by 323% in Q2 2026, buying an estimated $6.97M and bringing the position to 2,367,493 shares worth $9.97M. The position accounts for 0.01% of the portfolio, ranked #637.

Mackenzie Financial first reported a position in IRWD in Q2 2013 and has held it in 24 quarters since. 212 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

  • Mackenzie Financial held 2,367,493 shares of Ironwood Pharmaceuticals worth $9.97M as of Q2 2026.
  • Mackenzie Financial bought 1,807,459 Ironwood Pharmaceuticals shares in Q2 2026, an estimated $6.97M.
  • Ironwood Pharmaceuticals made up 0.01% of Mackenzie Financial's portfolio in Q2 2026, its #637 holding.
  • Mackenzie Financial first reported a position in Ironwood Pharmaceuticals in Q2 2013 and has held it in 24 quarters since.
  • 212 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on Mackenzie Financial's 13F filing for Q2 2026, filed 13 Aug 2026.